Work

Global and Regional Epidemiology of Early‐Onset Nasopharyngeal Carcinoma From 1990 to 2021

Year: 2026
Type: article
Abstract: OBJECTIVE: This study examined the global burden of early-onset nasopharyngeal carcinoma (NPC). STUDY DESIGN: Data on early-onset NPC patients aged 15 to 49 years from 1990 to 2021 were from GBD 2021 to evaluate disease burden and forecast to 2050. SETTING: Early-onset NPC patients aged 15 to 49 years; Global Burden of Disease (GBD) database 2021; period 1990 to 2021. METHODS: The burden of NPC was evaluated using incidence, mortality, disability-adjusted life-years (DALYs), sociodemographic index (SDI), and average annual percentage change (AAPC). Changes in risk factors affecting NPC were also analyzed. Bayesian age-period-cohort analysis was applied to forecast the disease burden spanning 2022 to 2050. RESULTS: Globally, the incidence, mortality, and DALYs of early-onset NPC all declined during 1990 to 2021. The AAPC of incidence, mortality, and DALYs were -0.32 (95% CI: -0.39 to -0.26), -2.12 (-2.16 to -2.08), and -2.09 (-2.13 to -2.05), respectively. The DALYs for NPC exhibited a markedly declining trend among various SDI regions over the 1990-2021 period. East Asia [AAPC: -3.19 (-3.26 to -3.12)] and Western Europe [AAPC: -3.04 (-3.16 to -2.96)] experienced the largest drops in DALYs from 1990 to 2021. High alcohol consumption, smoking, and formaldehyde exposure were major contributing factors to DALYs for early-onset NPC, with no significant changes observed between 1990 and 2021. From 2022 to 2050, the disease burden of early-onset NPC worldwide is projected to decline. CONCLUSIONS: Globally, the burden of early-onset NPC declined during 1990 to 2021 period and is projected to continue to decline in the future.
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W7234321356
FWCI:
Cites: 28
Cited by:
Related to: 10